Skip to main content

Table 1 USPSTF cancer screening eligibility criteria and intervals

From: Emergency department-based cancer screening interventions

Cancer Patient populationa Screening test(s) Recommended screening interval(s)
Breast Women age 50–74 years Screening mammogram Every 2 years
Cervical Women age 21–65 years Papanicolaou (Pap) test
High-risk human papillomavirus (hrHPV) test
Pap and hrHPV tests (co-testing)
Every 3 years
Every 5 years (age 30–65 only)
Every 5 years (age 30–65 only)
Colorectal Age 45–75 years Colonoscopy
Sigmoidoscopy
Fecal occult blood tests
Fecal immunochemical tests
CT colonography
Stool DNA tests (e.g., Cologuard)
Every 10 years
Every 5 years
Annually
Annually
Every 5 years
Every 1 to 3 years
Lung Age 50–80 years with a 20 pack-year smoking history and have smoked within the past 15 years Low-dose computed tomography (CT) of the chest Annually (until the individual has not smoked within 15 years)
  1. aPatient population refers to those individuals for whom the USPSTF has provided an A- or B-level recommendation for screening. Other patient sub-populations, based on personal and family history, can also benefit from screenings